Capsicum Pure

product on market Capsule Nutra Pure Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 25% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula combines Capsicum frutescens, CLA, and Garcinia cambogia, which are researched for their potential roles in metabolic support and weight management. Evidence for these ingredients varies from moderate to limited in clinical efficacy. The overall evidence coverage for this specific profile is very low at 0.25%.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Capsicum Pure
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
25%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Capsicum frutescens
400 mg
Market median: 1000.0mg (111 products)
Market median: 600.0mg (321 products) 5 studies — no high-quality reviews
Market median: 4002.0mg (1 products) 21 studies (A:0, B:2)

Other Ingredients

Vegetable capsule
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

SUGGESTED USE: As a dietary supplement, take two (2) capsules daily.

Warnings & Precautions

CAUTION: Do not exceed recommended dose.

Pregnant or nursing mothers, children under the age of 18, and individuals with a known medical condition should consult a physician before using this or any dietary supplement.

Pregnant or nursing mothers, children under the age of 18, and individuals with a known medical condition should consult a physician before using this or any dietary supplement.

KEEP OUT OF REACH OF CHILDREN.

DO NOT USE IF SAFETY SEAL IS DAMAGED OR MISSING.

Formulation Notes

Capsicum Extract

with Conjugated Linoleic Acid (CLA)

Additional Information

STORE IN A COOL, DRY PLACE.

Metadata

Product Details

DSLD Entry Date2013-06-25
Product TypeOther Combinations
FormCapsule
DSLD ID22319
Data Updated2026-04-11
Research

Research Evidence

2
Research Sources
40
Avg Quality
2
Clinical Trial
C Conjugated Linoleic Acid and Atherosclerosis
Clinical Trial ClinicalTrials.gov 2007
C Conjugated Linoleic Acid Supplementation Study
Clinical Trial ClinicalTrials.gov 2010
View all evidence for Conjugated Linoleic Acid →
Compare

Similar Products

View all Conjugated Linoleic Acid products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.